differences between tobolanza and coloverin d for irritable bowel syndrome treatment

differences between tobolanza and coloverin d for irritable bowel syndrome treatment (IBS). Both are widely used to treat gastrointestinal disorders such as cramps associated with indigestion, bloating, excess gas, and irritable bowel syndrome (IBS). They aim to relieve cramps and bloating and eliminate the resulting pain. Despite the similarity of the symptoms they treat, their pharmaceutical compositions differ, providing distinct properties in their mechanism of action and uses. In this article, we will discuss the active ingredients, mechanism of action, side effects, and the clear differences between them.

tobolanza ingredients

It consists of the following active ingredients:

• Valverin, an antispasmodic substance that relaxes cramping intestinal and stomach muscles and relieves the pain and discomfort associated with these muscle spasms.
• Simethicone belongs to a class of anti-flatulence and anti-gas medications. It works by reducing pressure and altering the surface tension of gas bubbles within the stomach and intestines. This results in small gas bubbles merging to form larger bubbles that are easier to expel and pass through the esophagus, reducing gas formation.

coloverin d Ingredients

It contains the following active ingredients:

• Dimethicone is a gas-repellent and anti-gas agent found in the stomach and intestines. This helps reduce intestinal and stoach spasms and treat indigestion.
• Mebeverine belongs to the anticholinergic group and works by inhibiting calcium entry into smooth muscles, reducing spasms, and relaxing the muscles of the intestines and stomach.

Author Name: Pharmacist Radwa Reda Elsaed

Scientific Degree: Pharmacist

Country: Egypt

Dr. Radwa Reda El-Saeed

PhD in Pharmacognosy | Clinical Pharmacist & Medical Content Reviewer

Holding a Bachelor of Pharmaceutical Sciences from Alexandria University and a PhD in Pharmacognosy, Dr. Radwa brings extensive clinical and academic expertise through community pharmacy practice and ongoing engagement with clinical research. 

At Rosheta, she authors and reviews pharmaceutical and medical content, adhering strictly to the latest therapeutic guidelines and verified medical references to ensure that readers receive accurate, evidence-based, and safe medication information.

Published Date: 23 August 2025